Literature DB >> 16831517

Oligodendrocytes express P2Y12 metabotropic receptor in adult rat brain.

S Amadio1, G Tramini, A Martorana, M T Viscomi, G Sancesario, G Bernardi, C Volonté.   

Abstract

In the CNS, nucleotide receptors termed P2 receptors are identified on neurons and glial cells, mediating neuron-neuron, glia-glia and glia-neuron communication. In the present work, we qualify in vivo in the adult rat CNS the cellular/subcellular distribution of P2Y12 receptor protein in cerebral cortex, white matter and subcortical nuclei (striatum and substantia nigra), by means of immunofluorescence-confocal, electron microscopy and Western blot analysis. P2Y12 receptor immunoreactivity colocalizes neither with markers such as neuronal nuclei, neurofilament light chain, calbindin and tyrosine hydroxylase, nor with glial fibrillary acidic protein and isolectin B4, but with myelin basic protein and the oligodendrocyte marker RIP, in both cell bodies and processes, indicating therefore oligodendrocyte localization. Electron microscopy identifies P2Y12 receptors in both the perikaryon and under the plasmalemma of oligodendrocyte cell bodies and radiating processes, until the paranodal region of fibers. By Western blot analysis, P2Y12 receptor shows a specific band of 42-44 kDa, matching the molecular mass predicted from amino acid sequencing. Since in platelets P2Y12 receptor is known to regulate adhesion/activation and thrombus growth/stability, from our results we could speculate by analogy that, in oligodendrocytes, P2Y12 receptor signaling might contribute to the migration and adhesion of the glial processes to axons to be myelinated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16831517     DOI: 10.1016/j.neuroscience.2006.05.058

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  20 in total

Review 1.  Purinergic trophic signalling in glial cells: functional effects and modulation of cell proliferation, differentiation, and death.

Authors:  Davide Lecca; Stefania Ceruti; Marta Fumagalli; Maria P Abbracchio
Journal:  Purinergic Signal       Date:  2012-04-12       Impact factor: 3.765

Review 2.  P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells.

Authors:  Christian Gachet
Journal:  Purinergic Signal       Date:  2012-04-11       Impact factor: 3.765

3.  Estrogen and P2 Purinergic Receptor Systems in Microglia: Therapeutic Targets for Neuroprotection.

Authors:  Jessica M Crain; Jyoti J Watters
Journal:  Open Drug Discov J       Date:  2010-01-01

Review 4.  P2Y receptors in the mammalian nervous system: pharmacology, ligands and therapeutic potential.

Authors:  Gary A Weisman; Lucas T Woods; Laurie Erb; Cheikh I Seye
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-09       Impact factor: 4.388

5.  P2Y12 receptor expression is a critical determinant of functional responsiveness to ATX's MORFO domain.

Authors:  Jameel Dennis; Magdalena K Morgan; Martin R Graf; Babette Fuss
Journal:  Purinergic Signal       Date:  2011-12-04       Impact factor: 3.765

Review 6.  P2 receptors for extracellular nucleotides in the central nervous system: role of P2X7 and P2Y₂ receptor interactions in neuroinflammation.

Authors:  Gary A Weisman; Jean M Camden; Troy S Peterson; Deepa Ajit; Lucas T Woods; Laurie Erb
Journal:  Mol Neurobiol       Date:  2012-04-01       Impact factor: 5.590

7.  P2Y1, P2Y6, and P2Y12 receptors in rat splenic sinus endothelial cells: an immunohistochemical and ultrastructural study.

Authors:  Kiyoko Uehara; Akira Uehara
Journal:  Histochem Cell Biol       Date:  2011-08-31       Impact factor: 4.304

Review 8.  Purinergic signaling in oligodendrocyte development and function.

Authors:  Taylor G Welsh; Sarah Kucenas
Journal:  J Neurochem       Date:  2018-03-25       Impact factor: 5.372

Review 9.  P2Y receptors in Alzheimer's disease.

Authors:  Laurie Erb; Chen Cao; Deepa Ajit; Gary A Weisman
Journal:  Biol Cell       Date:  2014-10-13       Impact factor: 4.458

10.  Emerging role of extracellular nucleotides and adenosine in multiple sclerosis.

Authors:  Marek Cieślak; Filip Kukulski; Michał Komoszyński
Journal:  Purinergic Signal       Date:  2011-07-27       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.